Next 10 |
home / stock / holx / holx articles
Stephens initiated coverage on Hologic Inc (NASDAQ:HOLX), citing it as a major player in women’s health, known for its consistent revenue gro...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrade...
West Pharmaceutical Services, Inc. (NYSE: WST) is well poised for growth, backed by the robust Proprietary Products segment and sustained strength ...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Hologic, Inc. (NASDAQ:HOLX) reported better-than-expected first-quarter financial results after the bell Thursday. Here's a look at the highli...
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise ...
Stocks rallied on Friday, reversing the negative session from Thursday, which had broken the longest winning streak in over two years, following ha...
U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Friday. Shares of Synaptics Incorporated (NASDAQ: SYNA) rose sharply on ...
U.S. stocks are priming for a lackluster open on Friday, with the index futures trading on a narrowly mixed note. Interest rate worries have likely...
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 09:00:08 ET Vijay Kumar from Evercore ISI issued a price target of $76.00 for HOLX on 2024-07-02 08:04:00. The adjusted price target was set to $76.00. At the time of the announcement, HOLX was trading at $74.1. The overall price target consensus is at $78.33 ...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2024 on Monday, July 29, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. In...